BLFS

BioLife Solutions, Inc. NASDAQ

Healthcare ·Medical - Instruments & Supplies ·US · biolifesolutions.com

$21.55

Mkt Cap $1.1B

52w Low $17.86 31.4% of range 52w High $29.62

50d MA $20.40 200d MA $23.77

P/E (TTM) -84.8x

EV/EBITDA -121.6x

P/B 2.7x

Debt/Equity 0.1x

ROE -1.2%

P/FCF 108.6x

RSI (14) —

ATR (14) —

Beta 2.00

50d MA $20.40

200d MA $23.77

Avg Volume 443.1K

About

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, incl…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 26, 2026	AMC	-0.02	0.04	+300.0%	22.48	+4.5%	+7.7%	+0.2%	-10.3%	-8.1%	-10.5%	—
Nov 6, 2025	AMC	0.00	0.04	+1900.0%	27.02	-0.6%	-4.0%	-2.7%	-3.6%	-4.1%	-7.0%	—
Aug 7, 2025	AMC	-0.03	-0.33	-888.4%	20.64	+6.4%	+9.9%	+8.4%	+16.6%	+24.4%	+22.7%	—
May 8, 2025	AMC	-0.05	0.04	+182.4%	22.36	-4.2%	+4.2%	+6.8%	+3.3%	-1.4%	-1.7%	—
Mar 3, 2025	AMC	-0.06	-0.01	+83.3%	24.51	-2.0%	+1.3%	+7.1%	+9.3%	+5.4%	+1.4%	—
Nov 12, 2024	AMC	-0.08	-0.02	+74.4%	26.50	-0.8%	-9.0%	-18.3%	-20.7%	-22.8%	-15.3%	—
Aug 8, 2024	AMC	-0.14	-0.06	+56.6%	22.74	+7.7%	+11.0%	+13.5%	+16.6%	+13.9%	+13.3%	—
May 9, 2024	AMC	-0.28	-0.23	+17.9%	18.01	-0.6%	+8.5%	+14.7%	+24.5%	+27.7%	+22.0%	—
Feb 29, 2024	AMC	-0.34	-0.30	+11.8%	16.90	-13.9%	+6.3%	+7.4%	+0.7%	+3.7%	+2.1%	—
Nov 9, 2023	AMC	-0.38	-0.67	-78.7%	11.39	-4.0%	-3.9%	-5.4%	+5.1%	+8.3%	+5.0%	—
Aug 8, 2023	AMC	-0.20	-0.23	-15.0%	18.39	-15.7%	-28.7%	-32.5%	-34.0%	-31.5%	-33.3%	—
May 10, 2023	AMC	-0.21	-0.32	-52.4%	18.61	-2.7%	-1.9%	+1.0%	+4.6%	+8.8%	+17.8%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Dec 29	HC Wainwright & Co.	Maintains	Buy → Buy	—	$24.90	$24.79	-0.4%	+0.9%	-1.0%	-2.9%	-4.1%	+1.6%
Nov 24	HC Wainwright & Co.	Maintains	Buy → Buy	—	$26.53	$26.54	+0.0%	-0.7%	+1.7%	+0.6%	-0.1%	-4.2%
Aug 8	HC Wainwright & Co.	Maintains	Buy → Buy	—	$20.64	$21.97	+6.4%	+9.9%	+8.4%	+16.6%	+24.4%	+22.7%
May 13	HC Wainwright & Co.	Maintains	Buy → Buy	—	$23.89	$23.93	+0.2%	-3.3%	-7.7%	-8.0%	-1.3%	-4.0%
Mar 6	HC Wainwright & Co.	Maintains	Buy → Buy	—	$26.25	$26.15	-0.4%	+2.1%	-1.6%	-5.3%	+1.4%	+0.1%
Jan 8	Northland Capital Markets	Maintains	Outperform → Outperform	—	$27.11	$27.50	+1.4%	+2.1%	-1.8%	-0.5%	-3.1%	-1.5%
Dec 19	Benchmark	Maintains	Buy → Buy	—	$24.98	$25.44	+1.8%	+4.5%	+9.6%	+5.6%	+6.1%	+8.2%
Dec 13	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$26.72	$26.77	+0.2%	-0.1%	+2.4%	+0.6%	-6.5%	-2.3%
Nov 18	HC Wainwright & Co.	Maintains	Buy → Buy	—	$21.02	$20.30	-3.4%	-2.6%	+6.8%	+19.0%	+20.8%	+23.7%
Nov 13	TD Cowen	Maintains	Buy → Buy	—	$26.50	$26.30	-0.8%	-9.0%	-18.3%	-20.7%	-22.8%	-15.3%
Nov 13	Craig-Hallum	Maintains	Buy → Buy	—	$26.50	$26.30	-0.8%	-9.0%	-18.3%	-20.7%	-22.8%	-15.3%
Aug 12	Craig-Hallum	Maintains	Buy → Buy	—	$25.25	$25.31	+0.2%	+2.2%	+5.0%	+2.6%	+2.0%	+2.4%
Aug 9	Northland Capital Markets	Maintains	Outperform → Outperform	—	$22.74	$24.48	+7.7%	+11.0%	+13.5%	+16.6%	+13.9%	+13.3%
Jul 17	TD Cowen	Maintains	Buy → Buy	—	$22.77	$22.57	-0.9%	-1.1%	-5.8%	-7.7%	-4.8%	-0.0%
May 13	Benchmark	Upgrade	Hold → Buy	—	$19.54	$20.66	+5.7%	+5.7%	+14.8%	+17.7%	+12.4%	+12.4%
Aug 10	Craig-Hallum	Maintains	Buy → Buy	—	$13.11	$13.03	-0.6%	-5.3%	-7.4%	-3.9%	-6.4%	-11.0%
Aug 9	TD Cowen	Maintains	Outperform → Outperform	—	$18.39	$15.51	-15.7%	-28.7%	-32.5%	-34.0%	-31.5%	-33.3%
Aug 9	Lake Street	Maintains	Buy → Buy	—	$18.39	$15.51	-15.7%	-28.7%	-32.5%	-34.0%	-31.5%	-33.3%
Jul 17	Stephens & Co.	Maintains	Overweight → Overweight	—	$19.62	$19.83	+1.1%	+2.8%	+3.7%	+3.1%	+2.1%	+2.3%
Mar 17	Stephens & Co.	Maintains	Overweight → Overweight	—	$19.98	$18.91	-5.4%	+7.7%	+3.9%	+10.4%	+4.9%	+7.7%
Mar 6	Oppenheimer	Maintains	Outperform → Outperform	—	$23.93	$23.98	+0.2%	-4.9%	-5.1%	-5.4%	-6.0%	-18.5%
May 10	Stephens & Co.	Maintains	Overweight → Overweight	—	$10.90	$11.51	+5.6%	+7.8%	-3.3%	+2.4%	+13.9%	+16.8%
May 10	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$10.90	$11.51	+5.6%	+7.8%	-3.3%	+2.4%	+13.9%	+16.8%
Apr 25	Oppenheimer	Upgrade	Perform → Outperform	—	$12.59	$13.35	+6.0%	+9.5%	+4.8%	+1.1%	+3.3%	+0.6%
Aug 13	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$48.06	$49.98	+4.0%	-5.7%	-5.0%	-7.8%	-7.9%	-3.9%
May 14	Benchmark	Downgrade	Buy → Hold	—	$29.53	$28.76	-2.6%	+0.7%	+3.5%	+7.9%	+6.5%	+11.5%
Mar 23	KeyBanc	Maintains	Overweight → Overweight	—	$38.57	$46.50	+20.6%	+8.8%	+1.0%	-2.2%	-7.4%	-8.3%
Mar 23	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$38.57	$46.50	+20.6%	+8.8%	+1.0%	-2.2%	-7.4%	-8.3%
Mar 23	Benchmark	Upgrade	Hold → Buy	—	$38.57	$46.50	+20.6%	+8.8%	+1.0%	-2.2%	-7.4%	-8.3%
Mar 22	KeyBanc	Maintains	Overweight → Overweight	—	$38.76	$39.09	+0.9%	-0.5%	+8.3%	+0.5%	-2.7%	-7.8%
Nov 10	KeyBanc	Maintains	Overweight → Overweight	—	$32.10	$32.95	+2.6%	+0.5%	+3.2%	-0.3%	+0.3%	-2.9%
Sep 22	Oppenheimer	Downgrade	Outperform → Perform	—	$26.40	$25.66	-2.8%	+2.2%	+3.0%	-1.1%	-0.6%	+2.4%
Sep 18	Cowen & Co.	Maintains	Outperform → Outperform	—	$25.43	$26.25	+3.2%	+7.0%	+3.8%	+6.1%	+6.9%	+2.6%
Aug 11	Benchmark	Downgrade	Buy → Hold	—	$22.57	$21.24	-5.9%	-12.2%	-18.8%	-16.4%	-17.9%	-14.1%
May 4	B. Riley FBR	Maintains	Buy → Buy	—	$10.54	$10.58	+0.4%	+8.8%	+17.8%	+18.8%	+24.3%	+29.1%
May 4	B. Riley Securities	Maintains	Buy → Buy	—	$10.54	$10.58	+0.4%	+8.8%	+17.8%	+18.8%	+24.3%	+29.1%
Mar 23	HC Wainwright & Co.	Maintains	Buy → Buy	—	$9.12	$9.05	-0.8%	-4.2%	+1.0%	+0.7%	+10.5%	+3.0%
Mar 12	B. Riley FBR	Maintains	Buy → Buy	—	$12.25	$11.00	-10.2%	-29.5%	-26.3%	-31.8%	-22.0%	-19.1%
Mar 12	B. Riley Securities	Maintains	Buy → Buy	—	$12.25	$11.00	-10.2%	-29.5%	-26.3%	-31.8%	-22.0%	-19.1%
Feb 24	Lake Street	Maintains	Buy → Buy	—	$15.63	$15.35	-1.8%	+0.9%	-2.7%	-5.2%	-6.7%	-9.5%
Feb 19	Benchmark	Maintains	Buy → Buy	—	$15.54	$16.11	+3.7%	+5.0%	+4.3%	+0.6%	+1.5%	-2.1%
Feb 6	B. Riley	Maintains	Buy → Buy	—	$14.30	$14.88	+4.1%	-3.0%	-3.4%	-3.1%	-2.2%	-0.3%
Dec 16	H.C. Wainwright	Maintains	Buy → Buy	—	$15.67	$16.00	+2.1%	-0.6%	+0.8%	+4.7%	+3.0%	-1.0%
Nov 21	Oppenheimer	Maintains	Outperform → Outperform	—	$15.55	$15.83	+1.8%	+6.0%	+8.1%	+7.1%	+4.8%	+5.7%
Sep 4	Northland Capital Markets	Maintains	Outperform → Outperform	—	$20.33	$20.84	+2.5%	-2.0%	-1.5%	-4.0%	-3.8%	-3.5%
Jul 22	H.C. Wainwright	Maintains	Buy → Buy	—	$17.53	$17.82	+1.7%	+7.4%	+10.0%	+13.5%	+11.1%	+9.9%
Oct 3	B. Riley FBR	Maintains	Buy → Buy	—	$16.51	$16.47	-0.2%	-15.9%	-18.8%	-17.4%	-21.5%	-19.9%
Oct 3	B. Riley Securities	Maintains	Buy → Buy	—	$16.51	$16.47	-0.2%	-15.9%	-18.8%	-17.4%	-21.5%	-19.9%
May 11	Maxim Group	Maintains	Buy → Buy	—	$8.25	$8.50	+3.0%	-3.5%	+4.5%	+7.9%	+5.0%	+9.7%
Nov 10	Maxim Group	Maintains	Buy → Buy	—	$5.15	$5.86	+13.8%	+14.8%	+20.6%	+18.3%	+19.6%	+10.5%

Recent Filings

8-K · 7.01 ! Medium

BioLife Solutions Inc. -- 8-K 7.01: Regulation FD Disclosure

BioLife Solutions disclosed an investor presentation, likely outlining its business strategy and financial outlook to capital markets participants.

Mar 2

8-K

BioLife Solutions Inc. -- 8-K Filing

BioLife Solutions achieved 29% revenue growth in 2025 driven by biopreservation media strength and completed a strategic divestiture to refocus as a pure-play cell processing company.

Feb 26

Data updated apr 24, 2026 9:59pm · Source: massive.com